The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia
Abstract
An imbalance of pro- and antiangiogenic factors may lead to preeclampsia (PE). In this prospective nested case-control study, we investigated whether first trimester serum levels of placental growth factor (PlGF), a potent angiogenic factor, and its soluble inhibitor, soluble fms-like tyrosine kinase 1 (sFlt1), distinguished women who developed PE (n = 40) from those who developed gestational hypertension (n = 40), delivered a small for gestational age (SGA) newborn (n = 40), or completed a full term normal pregnancy (n = 80). Compared with controls, serum PlGF levels were lower among women who developed PE (23 +/- 24 pg/ml vs. 63 +/- 145 pg/ml; P < 0.01) or gestational hypertension (27 +/- 19 pg/ml; P = 0.03), or who delivered a SGA newborn (21 +/- 16 pg/ml; P < 0.01). In contrast, serum sFlt1 levels did not markedly differ between the groups: PE, 1048 +/- 657 pg/ml; gestational hypertension, 942 +/- 437 pg/ml; SGA newborns, 1011 +/- 479 pg/ml; and normal controls, 973 +/- 490 pg/ml. Multivariable analysis adjusting for potential confounders and serum sFlt1 levels demonstrated a 3.7-fold (95% confidence interval, 1.2-12.5) increase in risk for PE for every log unit decrease in serum levels of PlGF compared with controls. Analyses for gestational hypertension and SGA were not significant. Examined in tertiles, the risk for PE was increased 28.7-fold (95% confidence interval, 2.3-351.0) in the third (<12 pg/ml) compared with the first (>39 pg/ml) PlGF tertile. First trimester serum levels of PlGF and sFlt1 may identify women at high risk for PE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
Self-citation(2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.107928 · Cited by 3,270
KHONG, T. Y., DE WOLF, F., ROBERTSON, W. B., & BROSENS, I. (1986) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1986.tb07830.x · Cited by 1,591
Pathogenesis and genetics of pre-eclampsia
Roberts, J., & Cooper, D. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03577-7 · Cited by 1,269
Pre-eclampsia: more than pregnancy-induced hypertension
Roberts, J. M., & Redman, C. W. G. (1993) · The Lancet · doi:10.1016/0140-6736(93)90889-o · Cited by 1,246
Fundamentals of Biostatistics.
Barath, E., & Rosner, B. A. (1992) · Biometrics · doi:10.2307/2532371 · Cited by 1,183
Intrauterine growth restriction
Resnik, R. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01780-x · Cited by 1,022
Regulation of Human Placental Development by Oxygen Tension
Genbacev, O., Zhou, Y., Ludlow, J. W., & Fisher, S. J. (1997) · Science · doi:10.1126/science.277.5332.1669 · Cited by 914
Chappell, L. C., Seed, P. T., Briley, A. L., Kelly, F. J., Lee, R., Hunt, B. J., Parmar, K., Bewley, S. J., Shennan, A. H., Steer, P. J., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)80010-5 · Cited by 786
Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk
Caritis, S., Sibai, B., Hauth, J., Lindheimer, M. D., Klebanoff, M., Thom, E., VanDorsten, P., Landon, M., Paul, R., Miodovnik, M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803123381101 · Cited by 664
Zhou, Y., McMaster, M., Woo, K., Janatpour, M., Perry, J., Karpanen, T., Alitalo, K., Damsky, C., & Fisher, S. J. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62567-9 · Cited by 640
Trial of Calcium to Prevent Preeclampsia
Levine, R. J., Hauth, J. C., Curet, L. B., Sibai, B. M., Catalano, P. M., Morris, C. D., DerSimonian, R., Esterlitz, J. R., Raymond, E. G., Bild, D. E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370201 · Cited by 634
Self-citationPrevention of Preeclampsia with Low-Dose Aspirin in Healthy, Nulliparous Pregnant Women
Sibai, B. M., Caritis, S. N., Thom, E., Klebanoff, M., McNellis, D., Rocco, L., Paul, R. H., Romero, R., Witter, F., Rosen, M., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310213291701 · Cited by 558
A Multivariate Analysis of Risk Factors for Preeclampsia
Eskenazi, B. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470020063033 · Cited by 436
Anson-Cartwright, L., Dawson, K., Holmyard, D., Fisher, S. J., Lazzarini, R. A., & Cross, J. C. (2000) · Nature Genetics · doi:10.1038/77076 · Cited by 418
Taylor, R. N., Grimwood, J., Taylor, R. S., McMaster, M. T., Fisher, S. J., & North, R. A. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.111 · Cited by 411
Self-citationKoga, K., Osuga, Y., Yoshino, O., Hirota, Y., Ruimeng, X., Hirata, T., Takeda, S., Yano, T., Tsutsumi, O., & Taketani, Y. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021942 · Cited by 403
Circulating Levels of Immunoreactive Cytokines in Women with Preeclampsia
Conrad, K. P., Miles, T. M., & Benyo, D. F. (1998) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1998.tb00398.x · Cited by 396
Treatment of hypertension in pregnant women
Sibai, B. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350407 · Cited by 366
Expression of Inflammatory Cytokines in Placentas from Women with Preeclampsia1
Benyo, D. F., Smarason, A., Redman, C. W. G., Sims, C., & Conrad, K. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7585 · Cited by 319
Preeclampsia is associated with reduced serum levels of placenta growth factor
Torry, D. S., Wang, H.-S., Wang, T.-H., Caudle, M. R., & Torry, R. J. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70021-3 · Cited by 286
Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic.
Ziche, M., Maglione, D., Ribatti, D., Morbidelli, L., Lago, C. T., Battisti, M., Paoletti, I., Barra, A., Tucci, M., Parise, G., et al. (1997) · PubMed · Cited by 277
Insulin Resistance and Its Potential Role in Pregnancy-Induced Hypertension
Seely, E. W., & Solomon, C. G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030241 · Cited by 268
PLASMA-URATE MEASUREMENTS IN PREDICTING FETAL DEATH IN HYPERTENSIVE PREGNANCY
Redman, C. W. G., Beilin, L. J., Bonnar, J., & Wilkinson, R. H. (1976) · The Lancet · doi:10.1016/s0140-6736(76)93024-5 · Cited by 265
Obesity and preeclampsia: the potential role of inflammation*1
WOLF, M. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01551-4 · Cited by 254
Self-citationGeva, E., Ginzinger, D. G., Zaloudek, C. J., Moore, D. H., Byrne, A., & Jaffe, R. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020195 · Cited by 253
Prevention of Preeclampsia With Low-Dose Aspirin in Healthy, Nulliparous Pregnant Women
Sibai, B. M., Caritis, S. N., Thom, E., Klebanoff, M., McNellis, D., Rocco, L., Paul, R. H., Romero, R., Witter, F., Rosen, M., et al. (1994) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199404000-00002 · Cited by 249
Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia
Tidwell, S. C., Ho, H.-N., Chiu, W.-H., Torry, R. J., & Torry, D. S. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.113129 · Cited by 231
Dechend, R., Homuth, V., Wallukat, G., Kreuzer, J., Park, J. K., Theuer, J., Juepner, A., Gulba, D. C., Mackman, N., Haller, H., et al. (2000) · Circulation · doi:10.1161/01.cir.101.20.2382 · Cited by 230
Polliotti, B. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(03)00338-7 · Cited by 229
First Trimester Insulin Resistance and Subsequent Preeclampsia: A Prospective Study
Wolf, M., Sandler, L., Muñoz, K., Hsu, K., Ecker, J. L., & Thadhani, R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1563 · Cited by 221
Self-citationTaufield, P. A., Ales, K. L., Resnick, L. M., Druzin, M. L., Gertner, J. M., & Laragh, J. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703193161204 · Cited by 208
High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy,
Thadhani, R. (1999) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(99)00400-7 · Cited by 199
Self-citationReuvekamp, A., Velsing‐Aarts, F. V., Poulina, I. E. J., Capello, J. J., & Duits, A. J. (1999) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1999.tb08107.x · Cited by 185
Early detection of preeclampsia
Dekker, G. A., & Sibai, B. M. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90245-m · Cited by 167
Livingston, J. C., Chin, R., Haddad, B., McKinney, E. T., Ahokas, R., & Sibai, B. M. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.108022 · Cited by 162
VEGF mRNA levels in placentae from pregnancies complicated by pre‐eclampsia
Cooper, J. C., Sharkey, A., Jones, D. S., Palmer, C. R., & Smith, S. K. (1996) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1996.tb09627.x · Cited by 154
Pascoal, I., Lindheimer, M. D., Nalbantian-Brandt, C., & Umans, J. G. (1998) · Journal of Clinical Investigation · doi:10.1172/jci557 · Cited by 142
Insulin Resistance Syndrome in Preeclampsia
Kaaja, R. (1998) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-1016251 · Cited by 106
Plasma Placenta Growth Factor Levels in Midtrimester Pregnancies
Tjoa, M. L., van Vugt, J. M. G., Mulders, M. A. M., Schutgens, R. B. H., Oudejans, C. B. M., & van Wijk, I. J. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01497-1 · Cited by 106
Pulse pressure and risk of preeclampsia: A prospective study
Thadhani, R. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)01192-3 · Cited by 93
Self-citationDjurovic, S., Clausen, T., Wergeland, R., Brosstad, F. R., Berg, K., & Henriksen, T. (2002) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2002.01330.x · Cited by 91
Decreased Maternal Serum Placenta Growth Factor in Early Second Trimester and Preeclampsia
Su, Y. N., Lee, C., Cheng, W., Shau, W. Y., Chow, S. N., & Hsieh, F. J. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01341-2 · Cited by 89
Increased Endothelial Monocyte Chemoattractant Protein-1 and Interleukin-8 in Preeclampsia
Kauma, S. W., Takács, P., Scordalakes, C., Walsh, S. W., Green, K. L., & Peng, T. C. C. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02169-5 · Cited by 81
Kauma, S. W., Bae-Jump, V. L., & Walsh, S. W. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6120 · Cited by 76
Evaluation of Methods Used in the Prediction of Hypertensive Disorders of Pregnancy
Conde‐Agudelo, A., Lede, R., & Belizán, J. M. (1994) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199403000-00027 · Cited by 73
Ong, C. Y. T., Liao, A. W., Cacho, A. M., Spencer, K., & Nicolaides, K. H. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01528-9 · Cited by 72
Neale, D. M., Demasio, K. A., Illuzzi, J. L., Chaiworapongsa, T., Romero, R. J., & Mor, G. (2003) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/jmf.13.1.39.44 · Cited by 64
Placenta growth factor is not an early marker for the development of severe preeclampsia
Livingston, J., Haddad, B., Gorski, L., Neblett, P., Ahokas, R. A., Ramsey, R. D., & Sibai, B. M. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.113877 · Cited by 53
Familial Risk of Preeclampsia in Newfoundland
Dawson, L. M., Parfrey, P. S., Hefferton, D., Dicks, E. L., Cooper, M., Young, D. C., & Marsden, P. A. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000017224.24670.82 · Cited by 43
Johnson, R. D., Sadovsky, Y., Graham, C. A., Anteby, E. Y., Polakoski, K. L., Huang, X., & Nelson, D. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.9.3059 · Cited by 24
Cited by
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
The “Great Obstetrical Syndromes” are associated with disorders of deep placentation
Brosens, I., Pijnenborg, R., Vercruysse, L., & Romero, R. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.08.009 · Cited by 1,568
Poon, L. C., Shennan, A., Hyett, J. A., Kapur, A., Hadar, E., Divakar, H., McAuliffe, F., da Silva Costa, F., von Dadelszen, P., McIntyre, H. D., et al. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12802 · Cited by 1,238
Powe, C. E., Levine, R. J., & Karumanchi, S. A. (2011) · Circulation · doi:10.1161/circulationaha.109.853127 · Cited by 967
Self-citationPlacental Origins of Preeclampsia: Challenging the Current Hypothesis
Huppertz, B. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.107607 · Cited by 893
Metadata
- Authors
- Thadhani, R., Mutter, W. P., Wolf, M., Levine, R. J., Taylor, R. N., Sukhatme, V. P., Ecker, J., & Karumanchi, S. A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-02
- Volume
- 89
- Issue
- 2
- Pages
- 770-775
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1991959440
- Cited by
- 453
- References
- 52
- FWCI
- 30.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.